Citigroup’s Adagene ADAG Stock Holding History

Citigroup’s Portfolio ADAG Stock Details ADAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-654	Closed	-$9K	–	5792
2021 Q3	$9K	Buy	+654	New	+$10.7K	﹤0.01%	5487
2021 Q2	–	Sell	-63,536	Closed	-$1.14M	–	6091
2021 Q1	$1.14M	Buy	+63,536	New	+$1.45M	﹤0.01%	2886

Other funds holding ADAG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Citigroup's ADAG Position: Q4 2021 in Review

Citigroup sold out of Adagene (ADAG) in Q4 2021, closing a stake of 654 shares — an estimated $9K sold.

Citigroup first reported a position in ADAG in Q1 2021 and held it in 2 quarters. The position peaked at $1.14M in Q1 2021. 16 funds tracked by Wall St. Rank hold ADAG as of Q4 2021.

Citigroup reported no remaining Adagene position as of Q4 2021 after selling out during the quarter.
Citigroup sold 654 Adagene shares in Q4 2021, an estimated $9K.
Citigroup first reported a position in Adagene in Q1 2021 and held it in 2 quarters.
Citigroup's Adagene position peaked at $1.14M in Q1 2021.
16 funds tracked by Wall St. Rank held Adagene as of Q4 2021.

Based on Citigroup's 13F filing for Q4 2021, filed 10 Feb 2022.